PLT Health Solutions Partners with Alethios to Help Consumer Brands Generate Clinical Validation of Finished Formulations
New collaboration elevates PLT's capability as a science-driven commercialization partner, giving customers access to faster, scalable clinical research designed to support science messaging
According to
Ramping Up Support for Consumer Brands
PLT has long invested in clinical substantiation for the more than 35 branded ingredients in its portfolio, helping customers launch products with stronger scientific foundations. Through the new partnership, that same mindset can now be focused on validating finished formulations.
Beyond simply offering access to a platform, PLT and Alethios will leverage a guided model in which PLT supports trial development as a strategic scientific partner. Customers can capitalize on PLT's ingredient-specific clinical expertise to execute high-quality human health research.
Alethios provides the operational engine to deliver rigorous studies with real-world relevance via a range of readily accessible interactive tools for end-to-end clinical research support. This platform ranges from digital study planning and IRB approval to participant recruitment, compliance monitoring and data reporting. This structure allows brands to move faster while maintaining rigorous science and commercial timelines.
Flexible Study Options for Broad-Ranging Brand Needs
The partnership is designed to support a range of study types based on customer goals, budget and stages of commercialization.
For some brands, that may mean rapid-turn consumer perception research focused on satisfaction, usage experience or preference insights. For others, it may involve more rigorous clinical designs using validated questionnaires, biomarker measurements and a range of other outcomes in randomized, controlled trials.
Because studies are developed individually with specific product and business objectives in mind, study designs are tailored to align with the target consumer, claims strategy and commercial opportunity.
"Consumer health brands assume that clinical research has to be slow, expensive and operationally cumbersome," said Zeenia Framroze, CEO and Founder of Alethios. "Our platform exists to lower the barriers to fast, rigorous and high-quality research for all. Partnering with PLT lets us pair that infrastructure with best-in-class ingredient science and commercialization expertise."
Faster Recruitment. Better Execution
A key advantage of the Alethios platform is its decentralized model, which helps reduce many of the traditional bottlenecks associated with clinical studies. Alethios manages a large, engaged participant community and deploys digital workflows designed to accelerate recruitment, simplify participation and improve study execution. That can help brands generate data on timelines better aligned with modern product development cycles, where speed to insight can be just as important as the insight itself.
Built for Claims. Built for Growth.
"As the industry evolves, many consumers are becoming savvier and seeking products with clinical validation. Consequently, brands are seeking ways to highlight the strength and efficacy of their formulations relative to the competition," explains
"This collaboration is designed to create more value for the brands we serve," said Stagg. "We can help science-driven brands further differentiate their offerings and create new messaging opportunities specific to their target consumer. We are excited at the potential for this alliance in the marketplace," he said.
About PLT Health Solutions
Headquartered in
About Alethios
Alethios is a software platform designed to lower the barriers to evidence generation in human health for both researchers and participants. The Alethios Study Planner and Study Operator enable robust, AI-assisted study design and rapid, streamlined execution of decentralized studies for researchers and organizations across the health industry. The Alethiad Participant Community engages citizen scientists across the United States in meaningful and accessible research participation. Alethios is headquartered in San Francisco, CA.
Media Contact:
Mark Falconer
Sciencewerks
Voice: 407-412-9705
E-mail: [email protected]
Company Contact:
Steve Fink
PLT Health Solutions, Inc.
E-mail: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/plt-health-solutions-partners-with-alethios-to-help-consumer-brands-generate-clinical-validation-of-finished-formulations-302788386.html
SOURCE PLT Health Solutions
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EcoOnline launches EcoOne for connected intelligence and real-time visibility across safety and sustainability operations
- Proxima Fusion Raises €411 Million at a €2.4B Valuation to Build Europe’s Commercial Fusion Champion
- Glice AG Addresses the 60th Ordinary ISU Congress 2026 on the Future of Ice Infrastructure for Skating
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share